Schwarz' Parcopa Clears FDA For Parkinson's Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
The company plans to launch carbidopa/levodopa rapid dissolve formulation Parcopa Sept. 27 with 40-person sales force. Schwarz hopes that Parcopa will help broaden the company's U.S. presence.